Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Al/ML Data sets
new
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
>
2016
Pharma News, 2016
FDA cites two European companies in separate warning letters
The FDA named two European drug manufacturers--Delarange Cosmetics & Healthcare of the Netherlands and Wallace Cameron of the U.
AZD9412 Clinical Trial Update
SOUTHAMPTON, UK I October 12, 2016 I Synairgen plc (LSE.
WHO reaches out to API makers to get prequalification for much-needed drugs
As part of its efforts to expand access and make certain drugs more affordable for the treatment of a variety diseases and conditions, the World Health Organization is inviting API manufacturers to ap...
Curis Expands Oncology Pipeline with an Oral Small Molecule PD-L1/TIM-3 Immune Checkpoint Antagonist
LEXINGTON, MA, USA I October 11, 2016 I Curis, Inc.
US clears Lundbeck’s IV epilepsy drug Carnexiv
US regulators have approved Lundbeck's Carnexiv, the first intravenous formulation of epilepsy drug carbamazepine.
Exelixis and Pfizer drugs compete in kidney cancer trial
Exelixis's drug Cabometyx outperformed Pfizer's Sutent in a clinical study for the treatment of metastatic kidney cancer, suggesting it has the potential to become a first-line treatment, rese...
Takeda and Crescendo Biologics enter into cancer drug development partnership
Takeda Pharmaceutical Company Limited and Crescendo Biologics Limited said early Monday they entered into a cancer drug development partnership worth up to $36 million and as much as $754 million in a...
UAE pharmaceutical market set to hit $5.7 billion by 2020 as medical tourism grows, says GlobalData
The pharmaceutical market in the United Arab Emirates (UAE) is set to grow from just over $3 billion in 2015 to $5.
Theranos ditches fingerstick blood tests, closing labs and cutting jobs
When Theranos CEO Elizabeth Holmes presented a new device at a conference this summer, it seemed to be a bid to distract from the company’s much-criticized blood-testing tech.
FDA Approves Carnexiv™ (carbamazepine) injection as Intravenous Short-Term Replacement Therapy for Certain Seizure Types
DEERFIELD, Ill.
Teva Announces Sale of UK and Ireland Actavis Assets and Operations
JERUSALEM--(BUSINESS WIRE) -- Oct.
Mylan to pay $465 million over EpiPen Medicaid rebate dispute
Mylan NV (MYL.
9
10
11
12
13
14
15
16
17
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Al/ML Data sets
Synthetic and Medicinal Chemistry
In silico drug design (CADD)
Discovery biology
ADME, DMPK
Functional ex vivo and in vivo models
Safety and Toxicology
Company
News & Media
Contact us
Trends in discovery compounds